United Therapeutics Corporation (UTHR) Ownership

$453.07

north_east
$9.63 (2.17%)
Day's range
$443.45
Day's range
$455.11

United Therapeutics Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 5.35 M $2.24 B   0.36% 11.87%
VANGUARD GROUP INC 11/07/2025 4.42 M $1.85 B   -0.68% 9.80%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 2.17 M $911.11 M   2.56% 4.82%
AVORO CAPITAL ADVISORS LLC 11/14/2025 2.02 M $847.74 M   -14.67% 4.48%
STATE STREET CORP 11/14/2025 1.92 M $805.98 M   -11.30% 4.26%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 1.40 M $586.38 M   -3.06% 3.10%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.25 M $522.91 M   4.11% 2.77%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 986.48 K $413.54 M   -22.52% 2.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 824.30 K $345.55 M   378.69% 1.83%
DARWIN GLOBAL MANAGEMENT, LTD. 11/14/2025 748.55 K $317.62 M   100.00% 1.66%
LSV ASSET MANAGEMENT 11/06/2025 686.71 K $287.88 M   -20.58% 1.52%
ASSETMARK, INC 11/06/2025 645.91 K $270.77 M   -9.77% 1.43%
INVESCO LTD. 11/13/2025 637.22 K $267.13 M   -27.97% 1.41%
CITIGROUP INC 11/10/2025 551.47 K $231.18 M   1,196.54% 1.22%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 512.82 K $214.99 M   -10.62% 1.14%
JANUS HENDERSON GROUP PLC 11/14/2025 454.72 K $190.57 M   61.52% 1.01%
NORTHERN TRUST CORP 11/14/2025 447.02 K $187.39 M   -1.15% 0.99%
MORGAN STANLEY 11/14/2025 438.80 K $183.95 M   10.39% 0.97%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2025 425.99 K $178.58 M   -21.20% 0.94%
LMR PARTNERS LLP 11/14/2025 401.00 K $168.10 M   100.00% 0.89%
CITIGROUP INC 11/10/2025 355.00 K $148.82 M   2,740.00% 0.79%
BANK OF NEW YORK MELLON CORP 11/03/2025 351.46 K $147.33 M   -3.04% 0.78%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 349.50 K $146.51 M   234.77% 0.77%
PACER ADVISORS, INC. 10/15/2025 339.07 K $142.14 M   -33.48% 0.75%
SWEDBANK AB 10/15/2025 329.12 K $137.97 M   -0.45% 0.73%
CITIGROUP INC 11/10/2025 325.00 K $136.24 M   2,500.00% 0.72%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 321.50 K $134.87 M   52.07% 0.71%
FULLER & THALER ASSET MANAGEMENT, INC. 11/13/2025 315.31 K $132.18 M   -18.54% 0.70%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 312.95 K $131.19 M   -6.83% 0.69%
CAPTION MANAGEMENT, LLC 11/14/2025 309.80 K $129.87 M   390.19% 0.69%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 300.93 K $126.15 M   162.82% 0.67%
FIRST TRUST ADVISORS LP 11/12/2025 300.50 K $125.97 M   -1.64% 0.67%
NUVEEN, LLC 11/12/2025 287.07 K $120.34 M   14.23% 0.64%
CITADEL ADVISORS LLC 11/14/2025 273.98 K $114.86 M   94.30% 0.61%
LORD, ABBETT & CO. LLC 11/13/2025 269.07 K $112.80 M   -1.69% 0.60%
MILLENNIUM MANAGEMENT LLC 11/14/2025 258.58 K $108.40 M   235.54% 0.57%
CAPTION MANAGEMENT, LLC 11/14/2025 253.60 K $106.31 M   406.19% 0.56%
EVERSEPT PARTNERS, LP 11/14/2025 253.22 K $106.15 M   326.54% 0.56%
FMR LLC 11/13/2025 250.33 K $104.94 M   -40.99% 0.56%
JPMORGAN CHASE & CO 11/26/2025 247.94 K $103.94 M   2.20% 0.55%
IKARIAN CAPITAL, LLC 11/14/2025 209.80 K $87.95 M   100.00% 0.47%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 208.54 K $87.42 M   -38.50% 0.46%
EPOCH INVESTMENT PARTNERS, INC. 11/13/2025 205.78 K $86.27 M   -29.40% 0.46%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 203.19 K $85.18 M   -28.72% 0.45%
AVORO CAPITAL ADVISORS LLC 11/14/2025 200.00 K $4.44 M   100.00% 0.44%
LEGAL & GENERAL GROUP PLC 11/13/2025 199.66 K $83.70 M   0.57% 0.44%
JANE STREET GROUP, LLC 11/14/2025 198.10 K $83.05 M   2,856.72% 0.44%
BANK OF AMERICA CORP /DE/ 11/14/2025 192.84 K $80.84 M   -9.35% 0.43%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 190.63 K $79.91 M   60.85% 0.42%
ALLIANCEBERNSTEIN L.P. 11/14/2025 180.40 K $75.63 M   -39.07% 0.40%

United Therapeutics Corporation institutional Ownership - FAQ's

During the previous two years, 1020 institutional investors and hedge funds held shares of United Therapeutics Corporation. The most heavily invested institutionals were:

BlackRock, Inc.: 5.35 M

VANGUARD GROUP INC: 4.42 M

RENAISSANCE TECHNOLOGIES LLC: 2.17 M

Avoro Capital Advisors LLC: 2.02 M

STATE STREET CORP: 1.92 M

WELLINGTON MANAGEMENT GROUP LLP: 1.4 M

90.60% of United Therapeutics Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 57.13 M shares in the last 24 months. This purchase volume represents approximately $25.88 B in transactions.